Taysha Gene Therapies Inc (TSHA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TSHA Annual Balance Sheets →
Examining balance sheet movements between Taysha Gene Therapies Inc and Jun 30 2025 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent455.41
Cash & Short-term Investments455.00
Deferred Offering Costs DE0.11
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.16
Total Current Assets461.43
Equipment/Property/Plant Net7.66
Other Assets, Noncurrent1.34
Operating Lease Right Of Use Asset9.16
Total Assets470.43
Liabilities
Accounts Payable, Current AC9.16
Accrued Liabilities And Other Liabilities5.37
Other Liabilities, Current11.44
Deferred Revenue, Current DE0.00
Total Current Liabilities25.98
Long-term debt49.26
Total Long-term Debt49.26
Other liabilities, Noncurrent7.93
Operating Lease Liability Noncurrent17.77
Total Liabilities83.17
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,186.84
Retained Earnings / Accumulated Deficit-800.35
Accumulated Other Comprehensive Income0.77
Other Equity0.77
Common Stockholder's Equity387.27
Total Stockholder's Equity387.27
Liabilities & Stockholder's Equity470.43
4 historic quarters locked

Sign in to unlock the full Taysha Gene Therapies Inc balance sheet history.

About Taysha Gene Therapies Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-344610

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.